MedPath

Effect of Sitagliptin on Adiponectin and oxidative stress in Diabetic Patients - Japan (START-J study)

Not Applicable
Conditions
type 2 diabetic patients
Registration Number
JPRN-UMIN000004721
Lead Sponsor
Suita municipal hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

1) The patient who takes insulin treatment 2) The patient who takes treatment with thiazolidinediones 3) The patient with severe renal function disorder 4) The patient who takes sulfonylurea medicine more than the following amount Glimepiride 2mg, Glibenclamide 1.25mg, Gliclazide 40mg

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath